1. Endo thinks it has the financial flexibility to weather the storm of opioid settlements — Takeda acquires celiac-focused PvP Biologics — Iovance jumps on buyout rumors — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Recent Posts

Title
Replies Views
Last Message
  1. anonymous
    Replies:
    36
    Views:
    1,892
  2. anonymous
    Replies:
    17
    Views:
    1,129
  3. anonymous
    Replies:
    3
    Views:
    92
  4. anonymous
    Replies:
    226
    Views:
    28,884
  5. Anonymous
    Replies:
    959
    Views:
    355,173
  6. anonymous
    Replies:
    28
    Views:
    2,013
  7. anonymous
    Replies:
    120
    Views:
    11,295
  8. Anonymous
    Replies:
    2,884
    Views:
    432,085
  9. anonymous
    Replies:
    33
    Views:
    9,783
  10. anonymous
    Replies:
    14
    Views:
    3,702
  11. anonymous
    Replies:
    6
    Views:
    311
  12. anonymous
    Replies:
    6
    Views:
    243
  13. Anonymous
    Replies:
    1,149
    Views:
    244,826
  14. anonymous
    Replies:
    4
    Views:
    204
  15. anonymous
    Replies:
    186
    Views:
    8,509
  16. anonymous
    Replies:
    3
    Views:
    105
  17. Anonymous
    Replies:
    4,171
    Views:
    267,389
  18. cafead
    Replies:
    0
    Views:
    7
  19. cafead
    Replies:
    0
    Views:
    10
  20. anonymous
    Replies:
    66
    Views:
    3,436
Loading...